Pre-order Enquiry
Request Free Sample
Global Nanomedicines Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15313181 | Publishing Date : 20-Feb-2020 | No. of pages : 90
Detailed TOC of Global Nanomedicines Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nanomedicines Revenue
1.4 Market Analysis by Type
1.4.1 Global Nanomedicines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nanoparticles
1.4.3 Nanoshells
1.4.4 Nanotubes
1.4.5 Nanodevices
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nanomedicines Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institute
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Nanomedicines Market Perspective (2015-2026)
2.2 Nanomedicines Growth Trends by Regions
2.2.1 Nanomedicines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nanomedicines Historic Market Share by Regions (2015-2020)
2.2.3 Nanomedicines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nanomedicines Market Growth Strategy
2.3.6 Primary Interviews with Key Nanomedicines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicines Players by Market Size
3.1.1 Global Top Nanomedicines Players by Revenue (2015-2020)
3.1.2 Global Nanomedicines Revenue Market Share by Players (2015-2020)
3.1.3 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nanomedicines Market Concentration Ratio
3.2.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2019
3.3 Nanomedicines Key Players Head office and Area Served
3.4 Key Players Nanomedicines Product Solution and Service
3.5 Date of Enter into Nanomedicines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Nanomedicines Historic Market Size by Type (2015-2020)
4.2 Global Nanomedicines Forecasted Market Size by Type (2021-2026)
5 Nanomedicines Breakdown Data by Application (2015-2026)
5.1 Global Nanomedicines Market Size by Application (2015-2020)
5.2 Global Nanomedicines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nanomedicines Market Size (2015-2020)
6.2 Nanomedicines Key Players in North America (2019-2020)
6.3 North America Nanomedicines Market Size by Type (2015-2020)
6.4 North America Nanomedicines Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nanomedicines Market Size (2015-2020)
7.2 Nanomedicines Key Players in Europe (2019-2020)
7.3 Europe Nanomedicines Market Size by Type (2015-2020)
7.4 Europe Nanomedicines Market Size by Application (2015-2020)
8 China
8.1 China Nanomedicines Market Size (2015-2020)
8.2 Nanomedicines Key Players in China (2019-2020)
8.3 China Nanomedicines Market Size by Type (2015-2020)
8.4 China Nanomedicines Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nanomedicines Market Size (2015-2020)
9.2 Nanomedicines Key Players in Japan (2019-2020)
9.3 Japan Nanomedicines Market Size by Type (2015-2020)
9.4 Japan Nanomedicines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nanomedicines Market Size (2015-2020)
10.2 Nanomedicines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nanomedicines Market Size by Type (2015-2020)
10.4 Southeast Asia Nanomedicines Market Size by Application (2015-2020)
11 India
11.1 India Nanomedicines Market Size (2015-2020)
11.2 Nanomedicines Key Players in India (2019-2020)
11.3 India Nanomedicines Market Size by Type (2015-2020)
11.4 India Nanomedicines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nanomedicines Market Size (2015-2020)
12.2 Nanomedicines Key Players in Central & South America (2019-2020)
12.3 Central & South America Nanomedicines Market Size by Type (2015-2020)
12.4 Central & South America Nanomedicines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Nanomedicines Introduction
13.1.4 Abbott Revenue in Nanomedicines Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 GE Healthcare
13.2.1 GE Healthcare Company Details
13.2.2 GE Healthcare Business Overview and Its Total Revenue
13.2.3 GE Healthcare Nanomedicines Introduction
13.2.4 GE Healthcare Revenue in Nanomedicines Business (2015-2020)
13.2.5 GE Healthcare Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
13.3.3 Johnson & Johnson Nanomedicines Introduction
13.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Nanomedicines Introduction
13.4.4 Merck Revenue in Nanomedicines Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Nanomedicines Introduction
13.5.4 Pfizer Revenue in Nanomedicines Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 CombiMatrix
13.6.1 CombiMatrix Company Details
13.6.2 CombiMatrix Business Overview and Its Total Revenue
13.6.3 CombiMatrix Nanomedicines Introduction
13.6.4 CombiMatrix Revenue in Nanomedicines Business (2015-2020)
13.6.5 CombiMatrix Recent Development
13.7 Celgene
13.7.1 Celgene Company Details
13.7.2 Celgene Business Overview and Its Total Revenue
13.7.3 Celgene Nanomedicines Introduction
13.7.4 Celgene Revenue in Nanomedicines Business (2015-2020)
13.7.5 Celgene Recent Development
13.8 Mallinckrodt
13.8.1 Mallinckrodt Company Details
13.8.2 Mallinckrodt Business Overview and Its Total Revenue
13.8.3 Mallinckrodt Nanomedicines Introduction
13.8.4 Mallinckrodt Revenue in Nanomedicines Business (2015-2020)
13.8.5 Mallinckrodt Recent Development
13.9 Sigma-Tau Pharmaceuticals
13.9.1 Sigma-Tau Pharmaceuticals Company Details
13.9.2 Sigma-Tau Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction
13.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2015-2020)
13.9.5 Sigma-Tau Pharmaceuticals Recent Development
13.10 Teva Pharmaceutical
13.10.1 Teva Pharmaceutical Company Details
13.10.2 Teva Pharmaceutical Business Overview and Its Total Revenue
13.10.3 Teva Pharmaceutical Nanomedicines Introduction
13.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2015-2020)
13.10.5 Teva Pharmaceutical Recent Development
13.11 Nanosphere
10.11.1 Nanosphere Company Details
10.11.2 Nanosphere Business Overview and Its Total Revenue
10.11.3 Nanosphere Nanomedicines Introduction
10.11.4 Nanosphere Revenue in Nanomedicines Business (2015-2020)
10.11.5 Nanosphere Recent Development
13.12 UCB SA
10.12.1 UCB SA Company Details
10.12.2 UCB SA Business Overview and Its Total Revenue
10.12.3 UCB SA Nanomedicines Introduction
10.12.4 UCB SA Revenue in Nanomedicines Business (2015-2020)
10.12.5 UCB SA Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Nanomedicines Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Nanomedicines Key Market Segments
Table 2. Key Players Covered: Ranking by Nanomedicines Revenue
Table 3. Ranking of Global Top Nanomedicines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nanomedicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nanoparticles
Table 6. Key Players of Nanoshells
Table 7. Key Players of Nanotubes
Table 8. Key Players of Nanodevices
Table 9. Key Players of Others
Table 10. Global Nanomedicines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Nanomedicines Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Nanomedicines Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Nanomedicines Market Share by Regions (2015-2020)
Table 14. Global Nanomedicines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Nanomedicines Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Nanomedicines Market Growth Strategy
Table 20. Main Points Interviewed from Key Nanomedicines Players
Table 21. Global Nanomedicines Revenue by Players (2015-2020) (Million US$)
Table 22. Global Nanomedicines Market Share by Players (2015-2020)
Table 23. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicines as of 2019)
Table 24. Global Nanomedicines by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Nanomedicines Product Solution and Service
Table 27. Date of Enter into Nanomedicines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 30. Global Nanomedicines Market Size Share by Type (2015-2020)
Table 31. Global Nanomedicines Revenue Market Share by Type (2021-2026)
Table 32. Global Nanomedicines Market Size Share by Application (2015-2020)
Table 33. Global Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 34. Global Nanomedicines Market Size Share by Application (2021-2026)
Table 35. North America Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Nanomedicines Market Share (2019-2020)
Table 37. North America Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 38. North America Nanomedicines Market Share by Type (2015-2020)
Table 39. North America Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 40. North America Nanomedicines Market Share by Application (2015-2020)
Table 41. Europe Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Nanomedicines Market Share (2019-2020)
Table 43. Europe Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Nanomedicines Market Share by Type (2015-2020)
Table 45. Europe Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Nanomedicines Market Share by Application (2015-2020)
Table 47. China Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 48. China Key Players Nanomedicines Market Share (2019-2020)
Table 49. China Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 50. China Nanomedicines Market Share by Type (2015-2020)
Table 51. China Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 52. China Nanomedicines Market Share by Application (2015-2020)
Table 53. Japan Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Nanomedicines Market Share (2019-2020)
Table 55. Japan Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Nanomedicines Market Share by Type (2015-2020)
Table 57. Japan Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Nanomedicines Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Nanomedicines Market Share (2019-2020)
Table 61. Southeast Asia Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Nanomedicines Market Share by Type (2015-2020)
Table 63. Southeast Asia Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Nanomedicines Market Share by Application (2015-2020)
Table 65. India Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 66. India Key Players Nanomedicines Market Share (2019-2020)
Table 67. India Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 68. India Nanomedicines Market Share by Type (2015-2020)
Table 69. India Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 70. India Nanomedicines Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Nanomedicines Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Nanomedicines Market Share (2019-2020)
Table 73. Central & South America Nanomedicines Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Nanomedicines Market Share by Type (2015-2020)
Table 75. Central & South America Nanomedicines Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Nanomedicines Market Share by Application (2015-2020)
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Product
Table 80. Abbott Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 81. Abbott Recent Development
Table 82. GE Healthcare Company Details
Table 83. GE Healthcare Business Overview
Table 84. GE Healthcare Product
Table 85. GE Healthcare Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 86. GE Healthcare Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 91. Johnson & Johnson Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Product
Table 95. Merck Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 96. Merck Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Product
Table 100. Pfizer Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 101. Pfizer Recent Development
Table 102. CombiMatrix Company Details
Table 103. CombiMatrix Business Overview
Table 104. CombiMatrix Product
Table 105. CombiMatrix Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 106. CombiMatrix Recent Development
Table 107. Celgene Company Details
Table 108. Celgene Business Overview
Table 109. Celgene Product
Table 110. Celgene Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 111. Celgene Recent Development
Table 112. Mallinckrodt Business Overview
Table 113. Mallinckrodt Product
Table 114. Mallinckrodt Company Details
Table 115. Mallinckrodt Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 116. Mallinckrodt Recent Development
Table 117. Sigma-Tau Pharmaceuticals Company Details
Table 118. Sigma-Tau Pharmaceuticals Business Overview
Table 119. Sigma-Tau Pharmaceuticals Product
Table 120. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 121. Sigma-Tau Pharmaceuticals Recent Development
Table 122. Teva Pharmaceutical Company Details
Table 123. Teva Pharmaceutical Business Overview
Table 124. Teva Pharmaceutical Product
Table 125. Teva Pharmaceutical Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 126. Teva Pharmaceutical Recent Development
Table 127. Nanosphere Company Details
Table 128. Nanosphere Business Overview
Table 129. Nanosphere Product
Table 130. Nanosphere Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 131. Nanosphere Recent Development
Table 132. UCB SA Company Details
Table 133. UCB SA Business Overview
Table 134. UCB SA Product
Table 135. UCB SA Revenue in Nanomedicines Business (2015-2020) (Million US$)
Table 136. UCB SA Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicines Market Share by Type: 2020 VS 2026
Figure 2. Nanoparticles Features
Figure 3. Nanoshells Features
Figure 4. Nanotubes Features
Figure 5. Nanodevices Features
Figure 6. Others Features
Figure 7. Global Nanomedicines Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Nanomedicines Report Years Considered
Figure 12. Global Nanomedicines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Nanomedicines Market Share by Regions: 2020 VS 2026
Figure 14. Global Nanomedicines Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Nanomedicines Market Share by Players in 2019
Figure 17. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicines as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2019
Figure 19. North America Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Nanomedicines Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 28. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 30. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 36. CombiMatrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 38. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Celgene Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 40. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 42. Sigma-Tau Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 44. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 46. Nanosphere Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Nanosphere Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 48. UCB SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. UCB SA Revenue Growth Rate in Nanomedicines Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Keyplayers in Global Nanomedicines Market Size, Status and Forecast 2020-2026
AbbottGE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Request Sample
Request Discount
